https://www.selleckchem.com/products/fr180204.html
032) levels compared to controls. Plasma phenylalanine levels highly correlated with the number of failed neuropsychological tests ( = 0.64, = 0.003), neuropsychiatric symptoms ( = 0.73, 001), motor evoked potential latency ( = 0.48, = 0.03, and parietal lobe atrophy. Our study provides strong evidence for a correlation between phenylalanine levels and clinical, neuropsychological, neurophysiologic, biochemical, and imaging alterations in adult patients with phenylketonuria. Our study provides strong evidence for a correlation b